Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29067065 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| Methane SCHEMBL28783787 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL29067048 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL29067047 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL29067053 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL29067061 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL3893739 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL17262710 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL29067072 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL27790739 | 0.98 | TSHR (0.57) | TSHRTP53SRD5A2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115591583-B | Preparation method and application of cellulose-MOF core-shell structure | 北京理工大学 | 2024-07-30 | — | — | CN | claimed |
| CN-114039089-B | Preparation method and application of amorphous MOF-based lithium-sulfur battery material | 河北工业大学 | 2024-02-02 | — | — | CN | claimed |
| CN-116903869-A | Zr-UiO-66-BA material, preparation method, application and saccharomyces cerevisiae concentration detection method | 贵州茅台酒股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-114039089-A | Preparation method and application of lithium-sulfur battery material based on amorphous MOF | 河北工业大学 | 2022-02-11 | — | — | CN | claimed |
| EP-3595808-B1 | ORGANIC - INORGANIC POROUS HYBRID MATERIAL, METHOD FOR OBTAINING IT AND USE THEREOF | INDUSTRIAS QUIM DEL EBRO S A (ES) | 2020-08-05 | — | — | EP | claimed |
| CN-106215964-B | A kind of liberation of hydrogen catalyst and preparation method thereof | 北京化工大学 | 2019-01-18 | — | — | CN | claimed |
| CN-101637465-A | Medical application of 1-methyl-2-amino terephthalate | TIANJIN MEDICAL UNEVERSITY CAN | 2010-02-03 | — | — | CN | claimed |
| CN-1090374-C | Circuit protective device comprising PTC condcutive liquid crystal polymer composition | EATON CORP (US) | 2002-09-04 | — | — | CN | claimed |
| CN-1149746-A | Circuit protective device comprising PTC condcutive liquid crystal polymer composition | EATON CORP (US) | 1997-05-14 | — | — | CN | claimed |
| CN-122006499-A | Composite nanofiber filter material for cooperatively removing particulate matters and sulfur dioxide and preparation method thereof | 中国科学院城市环境研究所 | 2026-05-12 | — | — | CN | disclosed |
| CN-120129537-A | Radiopharmaceutical MOF for medical imaging | 诺德制药股份有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250144595-A1 | METAL ORGANIC RESINS WITH PROTONATED AND AMINE-FUNCTIONALIZED ORGANIC MOLECULAR LINKERS | NORTHWESTERN UNIVERSITY | 2025-05-08 | — | — | US | disclosed |
| US-12233398-B2 | Metal organic resins with zirconium nodes | NORTHWESTERN UNIVERSITY (US) | 2025-02-25 | — | — | US | disclosed |
| CN-115591583-B | Preparation method and application of cellulose-MOF core-shell structure | 北京理工大学 | 2024-07-30 | — | — | CN | disclosed |
| US-6602871-B2 | Anticoagulants; compounds of given formula: several types of nitrogen containing heterocycles such as perhydroindolizine, piperazine, pyrimidine | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-08-05 | — | — | US | disclosed |
| CN-1090374-C | Circuit protective device comprising PTC condcutive liquid crystal polymer composition | EATON CORP (US) | 2002-09-04 | — | — | CN | disclosed |
| US-20020115854-A1 | Thrombin or factor Xa inhibitors | LAM PATRICK Y S (US) | 2002-08-22 | — | — | US | disclosed |
| CN-1149746-A | Circuit protective device comprising PTC condcutive liquid crystal polymer composition | EATON CORP (US) | 1997-05-14 | — | — | CN | disclosed |
| US-5324832-A | Muscarinic antagonists | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-06-28 | — | — | US | disclosed |
| WO-1993000906-A1 | MUSCARINIC ANTAGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115854-A1 | Thrombin or factor Xa inhibitors | SERPINC1, TFPI, SPINT2 | TSHR 1175/4885TP53 3061/4885SRD5A2 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.